Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Zolla-Pazner: Epitope-Scaffold Immunogens |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2010-04-05 |
| Study Made Public: | 2012-03-20 |
Title
NYU 9
Description
CAVD 317 (NYU-9) is a preclinical rabbit study to evaluate and compare the neutralization activity of sera following DNA/protein prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
DNA (gp120.C1-opt) V3/3074 CTB V3/H CTB V3/2219 CTB V3/BIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.